HL7 FHIR Implementation Guide Dossier Farmaceutico
0.1.1 - ci-build Italy flag

HL7 FHIR Implementation Guide Dossier Farmaceutico, published by HL7 Italia. This guide is not an authorized publication; it is the continuous build for version 0.1.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-it/dossier-pharma/ and changes regularly. See the Directory of published versions

ValueSet: AIFA Note

Official URL: http://hl7.it/fhir/dossier-pharma/ValueSet/vs-aifa-nota Version: 0.1.1
Active as of 2024-06-24 Computable Name: VsNotaAifa

Indicazioni terapeutiche per un determinato farmaco rimborsabile dal Servizio Sanitario Nazionale

References

Logical Definition (CLD)

 

Expansion

Expansion based on codesystem AIFA - Indicazioni terapeutiche (Nota AIFA) v0.1.1 (CodeSystem)

This value set contains 40 concepts

CodeSystemDisplay
  01http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: pantoprazolo, omeprazolo, misoprostolo, lansoprazolo, esomeprazolo
  02http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: acido chenoursodesossicolico, acido tauroursodesossicolico, acido ursodesossicolico
  04http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: duloxetina, gabapentin, pregabalin
  08http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: levocarnitina
  11http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Calcio folinato
  13http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in Nota: Ipolipemizzanti:Fibrati: bezafibrato, fenofibrato, gemfibrozil Statine: simvastatina, pravastatina, fluvastatina, lovastatina, atorvastatina, rosuvastatina Altri: PUFA-N3, ezetimibe
  15http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Albumina umana
  28http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Megestrolo, Medrossiprogesterone
  31http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Levodropropizina, Diidrocodeina Acido benzoico, Diidrocodeina
  36http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Testosterone
  39http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in nota: somatropina, Somatrogon
  41http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Calcitonina
  42http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Acido etidronico, Acido clodronico
  48http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Acido etidronico, Acido clodronico
  51http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in nota: Analoghi del LHRH: Buserelina, Goserelina, Leuprorelina, Triptorelina Modulatori selettivi del Recettore del Progesterone: Ulipristal acetato Antagonisti dell ormone di rilascio delle gonadotropine, estrogeno e progestinico (in associazione): relugolix, estradiolo (come emiidrato) (E2), noretisterone acetato (NETA)
  55http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Tobramicina, Piperacillina + Tazobactam, Piperacillina, Netilmicina, Mezlocillina, Gentamicina, Ceftazidima, Cefepime, Ampicillina + Sulbactam, Amikacina
  56http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Teicoplanina, Rifabutina, Imipenem + Cilastatina, Aztreonam
  65http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Glatiramer acetato - Interferone β-1a - Interferone β-1b - Teriflunomide - Dimetilfumarato - Peginterferone beta-1a
  66http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Tenoxicam, Sulindac, Proglumetacina, Piroxicam, Oxaprozina, Nimesulide, Naprossene, Nabumetone, Meloxicam, Lornoxicam, Ketoprofene, Indometacina, Ibuprofene, Furprofene, Flurbiprofene, Fentiazac, Etoricoxib, Diclofenac + Misoprostolo, Diclofenac, Dexibuprofene, Codeina e ibuprofene, Cinnoxicam, Celecoxib, Amtolmetina, Acido tiaprofenico, Acido mefenamico, Acetametacina, Aceclofenac
  74http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Urofollitropina, Menotropina, Lutropina alfa, Follitropina delta, Follitropina beta, Follitropina alfa/Lutropina alfa, Follitropina alfa, Coriogonadotropina alfa, Corifollitropina alfa
  75http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Vardenafil, Tadalafil, Sildenafil, Avanafil, Alprostadil
  79http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci a carico SSN inclusi nella 79: Alendronato, Bazedoxifene, Denosumab, Ibandronato, Raloxifene, Risedronato, Romosozumab, Teriparatide, Zoledronato
  82http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Zafirlukast, Montelukast
  83http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Carbomer
  84http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Valaciclovir, Famciclovir, Brivudina, Aciclovir
  85http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci a carico SSN inclusi nella 85: donepezil - galantamina - rivastigmina - memantina
  87http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in Nota: fesoterodina, ossibutina, solifenacina, tolterodina
  88http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Corticosteroidi, preparati dermatologici
  89http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Prometazina, Oxatomide, Mizolastina, Loratadina, Levocetirizina, Ketotifene, Fexofenadina, Ebastina, Desloratadina, Cetirizina, Acrivastina, Rupatadina
  90http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Naloxegol, Metilnaltrexone, Naldemedina
  91http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Febuxostat
  92http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Benzilpenicillina benzatinica
  93http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaco in nota: Midazolam oromucosale
  95http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in Nota : diclofenac 3% in ialuronato di sodio, 5-Fluorouracile/Acido salicilico (per la cheratosi attinica); Imiquimod crema 3,75%, 5-Fluorouracile 4%, Tirbanibulina 10 mg/g unguento (per la cheratosi attinica non ipercheratosica non ipertrofica).
  96http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in Nota: colecalciferolo, colecalciferolo/Sali di calcio, calcifediolo
  97http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in Nota: AVK : Warfarin, Acenocumarolo - NAO/DOAC : Dabigatran, Apixaban, Edoxaban, Rivaroxaban
  98http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in nota: aflibercept , bevacizumab (L. 648/96), brolucizumab, faricimab, ranibizumab
  99http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in Nota : medicinali per uso inalatorio (limitatamente ai dosaggi/formulazioni autorizzati per la terapia inalatoria di mantenimento della BPCO) a base dei seguenti principi attivi: LABA : Formoterolo, Indacaterolo, Olodaterolo, Salmeterolo - LAMA : Aclidinio, Glicopirronio, Tiotropio, Umeclidinio - LABA + ICS (unico erogatore) - Formoterolo/Beclometasone, Formoterolo/Budesonide, Salmeterolo/Fluticasone Propionato, Vilanterolo/Fluticasone Furoato - LABA + LAMA (unico erogatore): Indacaterolo/Glicopirronio, Vilanterolo/Umeclidinio, Olodaterolo/Tiotropio, Formoterolo/Aclidinio - ICS + LABA + LAMA (unico erogatore): Beclometasone Dipropionato/Formoterolo Fumarato Diidrato/Glicopirronio Bromuro, Fluticasone Furoato/ Umeclidinio Bromuro/ Vilanterolo Trifenatato, Budesonide/glicopirronio bromuro/ formoterolo fumarato diidrato.
  100http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in Nota: INIBITORI SGLT2: canagliflozin - dapagliflozin - empagliflozin - ertugliflozin AGONISTI RECETTORIALI GLP1: dulaglutide - exenatide - exenatide LAR - liraglutide - lixisenatide - semaglutide orale - semaglutide sottocutanea INIBITORI DPP4: alogliptin - linagliptin - saxagliptin - sitagliptin - vildagliptin ASSOCIAZIONI PRECOSTITUITE: canagliflozin/metformina - dapagliflozin/metformina - empagliflozin/metformina - empagliflozin/linagliptin - ertugliflozin/metformina - ertugliflozin/sitagliptin - saxagliptin/dapagliflozin - degludec/liraglutide - glargine/lixisenatide - alogliptin/metformina - alogliptin/pioglitazone - linagliptin/metformina - saxagliptin/metformina - sitagliptin/metformina - vildagliptin/metformina
  101http://hl7.it/fhir/dossier-pharma/CodeSystem/aifa-notaFarmaci in Nota: Anticoagulanti orali inibitori della vitamina K (AVK): warfarin - acenocumarolo Inibitori diretti della trombina o del fattore Xa (NAO/DOAC): dabigatran - apixaban - edoxaban - rivaroxaban

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code